| Dr Mary L Bradley-leboeuf, MD | |
|
1307 Lynn Ln, Idabel, OK 74745-6845 | |
| (580) 286-5437 | |
| (580) 286-3955 |
| Full Name | Dr Mary L Bradley-leboeuf |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1307 Lynn Ln, Idabel, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497724041 | NPI | - | NPPES |
| 100187600B | Medicaid | OK | |
| 22507 | Other | OK | STATE MED LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 22507 (Oklahoma) | Primary |
| Entity Name | Idabel Children's Clinic, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689985343 PECOS PAC ID: 5890980155 Enrollment ID: O20101111001156 |
News Archive
Columbia University Medical Center researchers have identified cells in the upper digestive tract that can give rise to Barrett's esophagus, a precursor to esophageal cancer. The discovery of this "cell of origin" promises to accelerate the development of more precise screening tools and therapies for Barrett's esophagus and esophageal adenocarcinoma, the fastest growing form of cancer in the U.S.
A University of Wisconsin-Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell. The cells in question are neurons and make the neurotransmitter dopamine, whose deficiency is the culprit in the widespread movement disorder Parkinson's disease.
A paper published in the Journal of Biomedical Optics (JBO), "Imaging hydroxyapatite in sub-retinal pigment epithelial deposits by fluorescence lifetime imaging microscopy with tetracycline staining," demonstrates a potential new diagnostic option for catching a degenerative eye disease in its earliest stages.
Some 7,000 U.S. hospital patients die each year and more than 750,000 are injured as a result of medication mistakes. These errors have many causes, and many potential solutions, according to a Rutgers-Camden nursing scholar who has studied the topic extensively.
The new treatment involves injecting thousands of the beads via an incision into the hepatic artery - the main blood supply for the liver. When the microspheres are injected they are picked up by the blood flow and eventually lodge in the malignant cells of the tumours.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mary L Bradley-leboeuf, MD 1307 Lynn Ln, Idabel, OK 74745-6845 Ph: (580) 286-5437 | Dr Mary L Bradley-leboeuf, MD 1307 Lynn Ln, Idabel, OK 74745-6845 Ph: (580) 286-5437 |
News Archive
Columbia University Medical Center researchers have identified cells in the upper digestive tract that can give rise to Barrett's esophagus, a precursor to esophageal cancer. The discovery of this "cell of origin" promises to accelerate the development of more precise screening tools and therapies for Barrett's esophagus and esophageal adenocarcinoma, the fastest growing form of cancer in the U.S.
A University of Wisconsin-Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell. The cells in question are neurons and make the neurotransmitter dopamine, whose deficiency is the culprit in the widespread movement disorder Parkinson's disease.
A paper published in the Journal of Biomedical Optics (JBO), "Imaging hydroxyapatite in sub-retinal pigment epithelial deposits by fluorescence lifetime imaging microscopy with tetracycline staining," demonstrates a potential new diagnostic option for catching a degenerative eye disease in its earliest stages.
Some 7,000 U.S. hospital patients die each year and more than 750,000 are injured as a result of medication mistakes. These errors have many causes, and many potential solutions, according to a Rutgers-Camden nursing scholar who has studied the topic extensively.
The new treatment involves injecting thousands of the beads via an incision into the hepatic artery - the main blood supply for the liver. When the microspheres are injected they are picked up by the blood flow and eventually lodge in the malignant cells of the tumours.
› Verified 4 days ago
Dr. Scott Martin Grigory, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1 W Main St, Suite 100, Idabel, OK 74745 Phone: 580-579-3385 |